Your account is not claimed yet. You can sign up with ORCID to claim your account.

Kathryn Aston-Mourney

Years Active: 2017-2023
Publications (10 Years): 6

Deakin University - Geelong Campus at Waurn Ponds

University of Melbourne (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Deakin University - Geelong Campus at Waurn Ponds

Australia

Lecturer :: Medicine

Education History

University of Melbourne

Australia

PHD :: Medicien

Publications

Smithamol Sithara, Tamsyn Crowley, Ken Walder, Kathryn Aston-Mourney
Identification of reversible and druggable pathways to improve beta-cell function and survival in Type 2 diabetes. Islets 15 (1) (2023)
Smithamol Sithara, Tamsyn Crowley, Ken Walder, Kathryn Aston-Mourney
Identification of reversible and druggable pathways to improve beta-cell function and survival in Type 2 diabetes. Islets 15 (1) (2023)
Smithamol Sithara, Tamsyn Crowley, Ken Walder, Kathryn Aston-Mourney
Identification of reversible and druggable pathways to improve beta-cell function and survival in Type 2 diabetes. Islets 15 (1) (2023)
Peter M Meggyesy, Shashank Masaldan, Sharnel A S Clatworthy, Irene Volitakis, Daniel J Eyckens, Kathryn Aston-Mourney, Michael A Cater
Copper Ionophores as Novel Antiobesity Therapeutics. Molecules (Basel, Switzerland) 25 (21) (2020)
Jacob McCann, Megan Ellis, Sean L McGee, Kathryn Aston-Mourney
Class IIa HDACs do not influence beta-cell function under normal or high glucose conditions. Islets 11 (5) (2019)
Vidhi Gaur, Timothy Connor, Kylie Venardos, Darren C Henstridge, Sheree D Martin, Courtney Swinton, Shona Morrison, Kathryn Aston-Mourney, Stefan M Gehrig, Roelof van Ewijk, Gordon S Lynch, Mark A Febbraio, Gregory R Steinberg, Mark Hargreaves, Ken R Walder, Sean L McGee
Scriptaid enhances skeletal muscle insulin action and cardiac function in obese mice. Diabetes, obesity & metabolism 19 (7) (2017)

Kathryn Aston-Mourney.css-eqlu8i{font-size:small;padding-left:4px;}